MedPath

SHIONOGI B.V.

🇬🇧United Kingdom
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

25

Active:19
Completed:5

Trial Phases

1 Phases

Phase 1:25

Drug Approvals

8

EMA:5
CIMA_AEMPS:3

Drug Approvals

Fetcroja

Authorization Status
Authorised
Approval Date
Apr 23, 2020
EMA

Fetcroja

Authorization Status
Authorised
Approval Date
Apr 23, 2020
EMA

Mulpleo (previously Lusutrombopag Shionogi)

Authorization Status
Authorised
Approval Date
Feb 18, 2019
EMA

Rizmoic

Authorization Status
Authorised
Approval Date
Feb 18, 2019
EMA

Senshio

Authorization Status
Authorised
Approval Date
Jan 14, 2015
EMA

Clinical Trials

Distribution across different clinical trial phases (25 trials with phase data)• Click on a phase to view related trials

Phase 1
25 (100.0%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.